Aurinia Pharmaceuticals Inc.
SEC CIK 1600620 · AUPH · last insider filing 2026-06-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Nova Tina Susan | Director | filed 2025 - 2026 |
| Johnson Craig A | Director | filed 2024 - 2026 |
| Bailey Jeffrey Allen | Director | filed 2023 - 2026 |
| Goetz Kathleen | Director | filed 2025 - 2026 |
| Tang Kevin C | Director · Chief Executive Officer | filed 2024 - 2026 |
| Greenleaf Peter | Director · Chief Executive Officer | filed 2021 - 2026 |
| Smith Karen L. | Director | filed 2023 - 2024 |
| Leversage Jill | Director | filed 2021 - 2024 |
| Jayne David R.W. | Director | filed 2021 - 2024 |
| Mackay-Dunn R. Hector | Director | filed 2021 - 2024 |
| Billen Daniel | Director | filed 2021 - 2024 |
| Balakrishnan Brinda | Director | filed 2021 - 2024 |
| Foster Robert T | Director | filed 2023 - 2023 |
| Milne George M JR | Director | filed 2021 - 2023 |
| Hagan Joseph P | Director | filed 2021 - 2023 |
| Walbert Timothy P | Director | filed 2021 - 2022 |
| Hayden Michael R | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hearne Michael S | Chief Financial Officer | filed 2026 - 2026 |
| Robertson Stephen P. | EVP, General Counsel | filed 2021 - 2026 |
| Cole Ryan | Chief Operating Officer | filed 2026 - 2026 |
| Keenan Greg | SVP, Chief Medical Officer | filed 2024 - 2026 |
| Donley Matthew Maxwell | Ex VP, Internal Operations | filed 2021 - 2026 |
| Miller Joseph M | Chief Financial Officer | filed 2021 - 2026 |
| Habig Scott Michael | Chief Commercial Officer | filed 2022 - 2024 |
| Knappertz Volker | EVP, Research and Development | filed 2022 - 2024 |
| Martin Michael Robert | Chief Business Officer | filed 2021 - 2023 |
| Colao Massimilano | Chief Commercial Officer | filed 2021 - 2022 |
| Huizinga Robert Bindert | Ex Vice President of Research | filed 2021 - 2022 |
| Solomons Neil | Chief Medical Officer | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.